Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-01-12

Clinical Trial Update: Intralesional Tetracycline Injection in the Treatment of Chalazia [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating intralesional tetracycline injections for chalazia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tetracycline (tetracycline)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Chalazia, Chalazion | EARLY_Phase 1 | Status: WITHDRAWN